Recursion Pharmaceuticals, Inc.
RXRX • NASDAQ
Recursion Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Najat Khan, with a market cap of $1.9B.
Market Cap$1.9B
Employees500.0
CEONajat Khan
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 4, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Recursion Pharmaceuticals, Inc. FAQ
Common questions about Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. is scheduled to report earnings for Q1 2026 on May 4, 2026 before market open. Analysts estimate revenue of $17.5M.
Recursion Pharmaceuticals, Inc. has approximately 500 employees.